Show simple item record

dc.creatorDickerson, Justin Ben
dc.date.accessioned2016-01-09T00:34:33Zen
dc.date.available2016-01-09T00:34:33Zen
dc.date.created2011-04en
dc.date.issued2011-04en
dc.identifierdoi:10.4161/hv.7.4.14189en
dc.identifier.bibliographicCitationHuman vaccines 2011 Apr; 7(4): 477-80en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Provenge:+revolutionary+technology+or+ethical+bust?&title=Human+vaccines+&volume=7&issue=4&date=2011-04&au=Dickerson,+Justin+Ben
dc.identifier.urihttp://dx.doi.org/10.4161/hv.7.4.14189en
dc.identifier.urihttp://hdl.handle.net/10822/1017649en
dc.description.abstractSipuleucel-T (known by the trade name, "Provenge") is the first prostate cancer vaccine approved by the Food and Drug Administration (FDA), and represents a new type of cancer therapy termed, Autologous Cellular Immunotherapy (ACT). This therapy has been described as a revolution in technology by clinicians and researchers alike. However, policy-makers and health economists question the efficacy of such treatment given its costs, while mainstream media often bemoan Provenge as yet another example of a healthcare system gone awry. This paper examines the debate for and against Provenge, and discusses why Medicare adoption of payment protocols for the vaccine may violate the egalitarian and feminist principles of distributive justice theory. The paper also acknowledges the larger context of the Provenge debate within the bioethical community; that is, how much should society be willing to invest to prevent death? The paper concludes by arguing for a more thorough ethical review of such new technologies by policy-makers prior to the adoption of funding protocols.en
dc.formatArticleen
dc.languageenen
dc.sourceeweb:338596en
dc.subjectAdoptionen
dc.subjectCanceren
dc.subjectDeathen
dc.subjectEthical Reviewen
dc.subjectFooden
dc.subjectHealthen
dc.subjectJusticeen
dc.subjectProstate Canceren
dc.subjectResearchersen
dc.subjectReviewen
dc.subjectTechnologyen
dc.subject.classificationAllocation of Health Care Resourcesen
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationEconomics of Health Careen
dc.titleProvenge: Revolutionary Technology or Ethical Bust?en
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885